Sun Pharmaceutical Industries Limited vs Surya Pharmaceutical Ltd
A side-by-side comparison of Sun Pharmaceutical Industries Limited (SUNPHARMA) and Surya Pharmaceutical Ltd (SURYAPHARM) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, Sun Pharmaceutical Industries Limited leads SUNPHARMA vs SURYAPHARM on 10 of 14 metrics (1 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
- Valuation22
- Profitability40
- Growth10
- Size & financial health31
Valuation
EvenHow expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
SUNPHARMA takes 4/4How efficiently each company turns capital and sales into profit. Higher is better.
Growth
SUNPHARMA takes 1/2Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
SUNPHARMA takes 3/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company has delivered good profit growth of 38.3% CAGR over last 5 years", "Company has been maintaining a healthy dividend payout of 33.4%", "Company is almost debt free."]
- − ["Stock is trading at 5.05 times its book value"]
- − ["Company has low interest coverage ratio.", "The company has delivered a poor sales growth of -34.2% over past five years.", "Company has a low return on equity of -51.2% over last 3 years.", "Company has high debtors of 1,363 days.", "Working capital days have increased from 2,034 days to 5,556 days"]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.